Showing results (1-10 of 260) with videos related to
Sort By:
Pageof 26
British Journal of Hospital Medicine (London, England : 2005)|April 4, 2022
Primary biliary cholangitis: advances in understanding and managementAlex Smith, Benjamin Giles, Richard J AspinallFrontline Gastroenterology|March 15, 2024
Novel, nurse-led early postdischarge clinic is associated with fewer readmissions and lower mortality following hospitalisation with decompensated cirrhosisBenjamin Giles, Kirsty Fancey, Karen Gamble, et al.British Journal of Hospital Medicine (London, England : 2005)|February 13, 2018
Reducing recurrent hospital admissions in patients with decompensated cirrhosisRichard J AspinallCurrent Opinion in Investigational Drugs (London, England : 2000)|February 28, 2006
SCV-07 (SciClone Pharmaceuticals/Verta)Richard J Aspinall, Paul J PockrosExpert Review of Vaccines|August 7, 2003
Live bacteria as the basis for immunotherapies against cancerJosé A Chabalgoity, Gordon Dougan, Pietro Mastroeni, et al.Frontline Gastroenterology|August 26, 2017
Prolonged cholestasis induced by endoscopic retrograde cholangiopancreatographyOlomuza Patani, Sian L Foulkes, Ramatoulie Njie, et al.British Journal of Hospital Medicine (London, England : 2005)|October 8, 2019
Challenges in the use of corticosteroids in the management of autoimmune hepatitisRoger W Chapman, Richard J Aspinall, Palak Trivedi, et al.BMC Gastroenterology|April 2, 2021
A randomised placebo controlled trial of VSL#3<sup>®</sup> probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver diseasePui Lin Chong, David Laight, Richard J Aspinall, et al.Clinical and Experimental Dermatology|February 10, 2023
Liver fibrosis for the dermatologist: a reviewMina M Raahimi, Amy Livesey, Jessica Hamilton, et al.Journal of Hepatology|August 1, 2017
Universal screening for alcohol misuse in acute medical admissions is feasible and identifies patients at high risk of liver diseaseGreta Westwood, Paul Meredith, Susan Atkins, et al.Pageof 26